Smoke rising from Eastern Ghouta, on the outskirts of Damascus, following fresh air strikes and rocket fire on Feb. 27, 2018. Photo: Stringer / AFP / Getty Images

On Saturday the UN Security Council voted unanimously in favor of a ceasefire in Syria, amid an escalation of attacks by pro-Assad forces on Eastern Ghouta that has left at least 520 dead and 2,500 injured in the past five days. The resolution provides for a 30-day nationwide ceasefire, weekly UN aid convoys and medical evacuations, but has several glaring weak points.

The problems:

  • The ceasefire does not apply to ISIS or al-Qaeda, which raises fears that Russia and Assad will invoke the limited presence of Hay'at Tahrir al-Sham, an al-Qaeda affiliate, to continue the campaign against Eastern Ghouta.
  • No enforcement mechanisms are spelled out, even though the Syrian government has violated past ceasefires and Russia is an unreliable guarantor.
  • The violence in Eastern Ghouta is already a direct violation of existing de-escalation agreements backed by Russia, Turkey and Iran in the Astana framework.

What’s next: These weaknesses are arguably already undercutting the ceasefire. The Syrian government continues to pound Eastern Ghouta, with monitors reporting at least 30 killed since the resolution passed. The Syrian American Medical Society, a humanitarian organization, just verified another use of chemical weapons that affected 16 civilians, including six children. And Russia's announcement on Monday of a "humanitarian corridor," ostensibly to offer safe exit for civilians, is likely to be another loosely disguised means of forced displacement.

The bottom line: It’s the need for Russian buy-in that causes ceasefires to pass with these dangerous carve-outs and weak enforcement mechanisms, to further a strategic narrative that it is helping Damascus combat terrorism. The UN, and chiefly the United States, must capitalize on growing global awareness of the carnage in Ghouta to put firm measures in place that will protect civilian lives and create space for a peaceful resolution to the seven-year-old conflict.

Adham Sahloul has been a researcher at the Atlantic Council's Rafik Hariri Center for the Middle East and an advocacy officer at the Gaziantep, Turkey, office of SAMS.

Go deeper

Updated 8 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 9 p.m. ET: 20,755,406 — Total deaths: 752,225— Total recoveries: 12,917,934Map.
  2. U.S.: Total confirmed cases as of 9 p.m. ET: 5,246,760 — Total deaths: 167,052 — Total recoveries: 1,774,648 — Total tests: 64,831,306Map.
  3. Politics: House Democrats to investigate scientist leading "Operation Warp Speed" vaccine projectMcConnell announces Senate will not hold votes until Sept. 8 unless stimulus deal is reached.
  4. 2020: Biden calls for 3-month national mask mandateBiden and Harris to receive coronavirus briefings 4 times a week.
  5. States: Georgia Gov. Brian Kemp to drop lawsuit over Atlanta's mask mandate.
  6. Business: Why the CARES Act makes 2020 the best year for companies to lose money.
  7. Public health: Fauci's guidance on pre-vaccine coronavirus treatments Cases are falling, but don't get too comfortable.

Trump says he intends to give RNC speech on White House lawn

President Trump speaking to reporters on South Lawn in July. Photo: Jabin Botsford/The Washington Post via Getty Images

President Trump told the New York Post on Thursday that he plans to deliver his Republican National Convention speech from the White House lawn, despite bipartisan criticism of the optics and legality of the location.

Why it matters: Previous presidents avoided blurring staged campaign-style events — like party conventions — with official business of governing on the White House premises, per Politico.

Fauci's guidance on pre-vaccine coronavirus treatments

Illustration: Aïda Amer/Axios

Antibody drugs and various medicine cocktails against the coronavirus are progressing and may provide some relief before vaccines.

The big picture: Everyone wants to know how and when they can return to "normal" life, as vaccines are not expected to be ready for most Americans for at least a year. Two therapies are known to be helpful, and more could be announced by late September, NIAID Director Anthony Fauci tells Axios.